
Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 27, 2026 - 01:03:25
Radio and PodcastLive Radio & Podcasts
In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the importance of considering viability alongside safety and efficacy in cell and gene the...
Carl Schoellhammer: viability is the crucial third pillar in CGT is an episode from Ori Spotlight by Ori Biotech. In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to disc...
This episode belongs to Ori Spotlight.
Use the player on this page to stream the episode online.
Published Jun 25, 2024, 00:48:55 long, audio available.